ArticleInfection and immunity2018
Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Open access · bronzeAbstract read
In one paragraph
Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 45 citations in OpenAlex.
- No innocent bystanders: pertussis vaccination and evolutionary parallelisms betweenMicrobial genomics · 2025Article
- Intranasal application of a bifunctional pertactin-RTX fusion antigen elicits protection of mouse airway mucosa againstmSphere · 2025Article
- Mucosal IgA Antibodies are Critical for Bacterial Clearance ofPathogens & immunity · 2025Article
- Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective againstInfection and immunity · 2024Article
- Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice.NPJ vaccines · 2024Article
- BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.Infection and immunity · 2024Article
- The Neonatal Immune System and Respiratory Pathogens.Microorganisms · 2023Review
- Review
- Coping Strategies for Pertussis Resurgence.Vaccines · 2023Review
- Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.PloS one · 2023Article
- Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reducesFrontiers in immunology · 2023Article
- Article
- Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.Frontiers in immunology · 2022Article
- Reinvestigating the Coughing Rat Model of Pertussis To UnderstandInfection and immunity · 2021Article
- Mucosal Immunization with DTaP Confers Protection againstInfection and immunity · 2021Article
- Vaccine-Induced Cellular Immunity againstVaccines · 2021Review
- The Path to New Pediatric Vaccines against Pertussis.Vaccines · 2021Review
- Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.Infection and immunity · 2021Article
- Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses.Frontiers in microbiology · 2021Article
- Highlights of the 12th International Bordetella Symposium.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 3 institutions in 1 country.
Dylan T BoehmDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Jesse M HallDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Ting Y WongDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Andrea M DiVenereDepartment of Chemical Engineering, University of Texas at Austin, Austin, Texas, USA.
Emel Sen-KilicDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Justin R BevereDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Shelby D BradfordDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Catherine B BlackwoodDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Cody M ElkinsDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Katherine A DeRoosDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Mary C GrayDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
C Garret CooperVaccine Development Center at West Virginia University Health Sciences Center, Morgantown, West Virginia, USA.
Melinda E VarneyDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
Jennifer A MaynardDepartment of Chemical Engineering, University of Texas at Austin, Austin, Texas, USA.ORCID https://orcid.org/0000-0002-0363-8486
Erik L HewlettDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Mariette BarbierDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA.
F Heath DamronDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, West Virginia, USA fdamron@hsc.wvu.edu.ORCID https://orcid.org/0000-0002-3140-402X
West Virginia University · USThe University of Texas at Austin · USUniversity of Virginia · US
Funding
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1MWest Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2012 to 2016
$4.8MSystematic evaluation of B. pertussis ACT’s role as a protective antigenR01AI122753 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MAYNARD, JENNIFER A · 2016 to 2020
$1.9MSpecial Becton Dickinson Fortessa Flow CytometerS10OD016165 · OD · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2013 to 2013
$384kNIAID NIH HHS HHSN272201200005CNIAID NIH HHS R01 AI122753NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P30 GM103488NIH HHS S10 OD016165
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adenylyl CyclasesAnimalsAntibodies, BacterialAntibodies, NeutralizingBordetella pertussisDrug Evaluation, PreclinicalHumansMicePertussis VaccineToxoidsWhooping CoughAdenylyl CyclasesAntibodies, BacterialAntibodies, NeutralizingPertussis VaccineToxoidsacellular pertussis vaccinesadenylate cyclase toxinBordetella pertussisDTaPpertussisvaccineswhooping cough
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.